Filing Details

Accession Number:
0001140361-12-025908
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-05-16 20:22:12
Reporting Period:
2012-05-15
Filing Date:
2012-05-16
Accepted Time:
2012-05-16 19:22:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
864683 Cyberonics Inc CYBX Electromedical & Electrotherapeutic Apparatus (3845) 760236465
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400857 Jeffrey Daniel Moore 100 Cyberonics Blvd
Houston TX 77058
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-05-15 4,000 $14.72 263,915 No 4 A Direct
Common Stock Disposition 2012-05-15 4,000 $39.61 259,915 No 4 S Direct
Commom Stock Disposition 2012-05-15 3,000 $39.61 256,915 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option to purchase common stock Acquisiton 2012-05-15 4,000 $14.72 4,000 $14.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
248,908 2019-06-09 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 50,000 Indirect Daniel J. Moore 2011 GRAT I Trust
Common Stock 50,000 Indirect Grace M. Moore 2011 GRAT I Trust
Common Stock 33,000 Indirect 33000 Moore Family 2012 Gift Trust
Footnotes
  1. Represents weighted average selling price. Securities were sold through approximately 41 separate sales on the transaction date at prices ranging from $39.24 to $39.91. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.
  2. Shares sold pursuant to 10b5-1 Plan.
  3. Reporting Person was granted an option to purchase 40,760 shares of common stock on June 8, 2009. The option is fully vested and expires June 9, 2019. The option was subject to certain vesting and forfeiture requirements in accordance with the terms of the applicable Stock Option Agreement.